Latest News in the pharma Industry

Top Stories

NHS to Change HPV Vaccine Supplier

NHS to Change HPV Vaccine Supplier

28 Nov 2011

The UK will select Merck's Gardasil vaccine instead of GSK's rival product Cervarix to prevent girls from contracting the HPV virus.

Read more 
Provesica Publishes XEN-D0501 Phase 1 Data

Provesica Publishes XEN-D0501 Phase 1 Data

25 Nov 2011

XEN-D0501 is currently being assessed for efficacy in overactive bladder in an international phase 2 clinical study.

Read more 
Celldex Presents Data from Rindopepimut Phase II Trial

Celldex Presents Data from Rindopepimut Phase II Trial

25 Nov 2011

Data demonstrated a median overall survival of 24.6 months from diagnosis, which is consistent with the finding of two earlier studies.

Read more 
Asahi Kasei Acquires Artisan Pharma

Asahi Kasei Acquires Artisan Pharma

24 Nov 2011

The transaction establishes a U.S. presence for Asahi Kasei Pharma and provides access to the global development and commercialization of ART-123.

Read more 
Aeterna Zentaris & Hikma Ink Pact for Anti-cancer Compound

Aeterna Zentaris & Hikma Ink Pact for Anti-cancer Compound

24 Nov 2011

Hikma Pharmaceuticals will be responsible for the registration and commercialization of perifosine in the Middle East and North Africa region.

Read more 
Merck to Pay $950M in Vioxx Settlement

Merck to Pay $950M in Vioxx Settlement

24 Nov 2011

Merck has reached settlement with federal and state authorities over arthritis treatment Vioxx and will pay nearly $1bn in the settlement.

Read more 
Pfizer to Acquire Excaliard Pharmaceuticals

Pfizer to Acquire Excaliard Pharmaceuticals

23 Nov 2011

Pfizer has signed an agreement to acquire privately owned biopharmaceutical company Excaliard Pharmaceuticals.

Read more 
Gilead to Acquire Pharmasset for $11B

Gilead to Acquire Pharmasset for $11B

22 Nov 2011

Gilead Sciences, the world’s largest maker of HIV medicines, plans to buy Pharmasset Inc. for about $11 billion.

Read more 
Sundia Wins 2011 Zero2IPO Venture 50 Award

Sundia Wins 2011 Zero2IPO Venture 50 Award

22 Nov 2011

Sundia MediTech was named one of the 50 best companies for investment in China in 2011 by Zero2IPO.

Read more 
Par Pharmaceutical Completes Acquisition of Anchen

Par Pharmaceutical Completes Acquisition of Anchen

21 Nov 2011

Par Pharmaceutical Companies Inc. has announced the completion of the acquisition of privately-held Anchen Pharmaceuticals.

Read more 
Eisai Inks Pact with Novartis Pharma for COPD Therapies

Eisai Inks Pact with Novartis Pharma for COPD Therapies

21 Nov 2011

The new co-promotion agreement is a partnership of mutual commitment between Eisai and Novartis Pharma.

Read more 
Breast Cancer Drug Avastin Revoked

Breast Cancer Drug Avastin Revoked

21 Nov 2011

FDA is revoking the approval of the breast cancer indication for Avastin after concluding that the drug has not been shown to be safe and effective for that use.

Read more